[ENZ] Enzo Biochem, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical Specialities

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 6.9 Change: 0.05 (0.73%)
Ext. hours: Change: 0 (0%)

chart ENZ

Refresh chart

Strongest Trends Summary For ENZ

ENZ is in the long-term down -73% below S&P in 4 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Enzo Biochem, Inc., an integrated life sciences and biotechnology company, engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company operates in three segments: Clinical Labs, Life Sciences, and Therapeutics. The Clinical Labs segment provides routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. This segment operates a full-service clinical laboratory in Farmingdale, New York; a network of approximately 35 patient service centers in New York and New Jersey; and a standalone laboratory in the New York, as well as a full-service phlebotomy, in-house logistics department, and information technology department. The Life Sciences segment manufactures, develops, and markets products and tools to life sciences, drug developmen

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -3.7% Sales Growth - Q/Q3.87% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-23.75% ROE-40.8% ROI
Current Ratio1.6 Quick Ratio1.25 Long Term Debt/Equity Debt Ratio0.66
Gross Margin43.84% Operating Margin-13.29% Net Profit Margin-14.35% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities6.37 M Cash From Investing Activities-1.17 M Cash From Operating Activities-8.17 M Gross Profit10.48 M
Net Profit-2.91 M Operating Profit-2.85 M Total Assets58.52 M Total Current Assets36.06 M
Total Current Liabilities22.54 M Total Debt3.41 M Total Liabilities24.46 M Total Revenue23.99 M
Technical Data
High 52 week4.94 Low 52 week2.46 Last close3.73 Last change1.08%
RSI51.34 Average true range0.25 Beta1.59 Volume42.07 K
Simple moving average 20 days-0.2% Simple moving average 50 days0.3% Simple moving average 200 days10.75%
Performance Data
Performance Week6.27% Performance Month2.75% Performance Quart0.54% Performance Half-6.98%
Performance Year-7.44% Performance Year-to-date34.17% Volatility daily4.26% Volatility weekly9.51%
Volatility monthly19.5% Volatility yearly67.55% Relative Volume117.6% Average Volume243.91 K
New High New Low

News

2020-05-20 08:00:10 | Enzo Biochem Launches Proprietary Test for Detection of Coronavirus SARS-CoV-2 IgG Antibody Under FDA’s Emergency Use Authorization

2020-05-12 08:00:10 | Enzo Announces Issuance of U.S. Patent for Methods of Producing Monoclonal Antibodies Against Osteoporosis Drug Target Sclerostin

2020-04-29 08:00:10 | Enzo Announces Issuance of U.S. Patent for Methods of Using Proprietary Compound SK1-I in Patients; Exploring Options for Development as a Potential Treatment for COVID-19

2020-04-23 08:00:00 | Enzo Biochem Launches Proprietary COVID-19 Diagnostic Test Under FDA’s Emergency Use Authorization

2020-03-24 07:50:00 | Enzo Biochem says its subsidiary will conduct COVID-19 drive-through testing on Long Island

2020-03-24 07:30:00 | Enzo Biochem’s Clinical Labs Subsidiary Launches Drive-Through Facility to Provide COVID-19 Testing on Long Island

2020-03-20 06:00:00 | RPT-How one elite New York medical provider got its patients coronavirus tests

2020-03-20 01:00:00 | How one elite New York medical provider got its patients coronavirus tests

2020-03-09 14:44:16 | Is Inovio Pharmaceuticals Stock the Cure for Your Portfolio?

2020-03-09 11:42:12 | Should You Be Concerned About Enzo Biochem, Inc.'s NYSE:ENZ ROE?

2020-03-06 18:27:06 | Edited Transcript of ENZ earnings conference call or presentation 6-Mar-20 1:30pm GMT

2020-03-06 08:00:00 | Enzo Biochem’s Full Service Clinical Laboratory to Launch Coronavirus COVID-19 Testing Services Next Week

2020-03-06 06:30:00 | Enzo Biochem, Inc. to Host Earnings Call

2020-03-05 16:05:00 | Enzo Biochem Reports Fiscal Second Quarter Results

2020-03-03 10:00:00 | Enzo Biochem Schedules Teleconference to Discuss Second Quarter 2020 Results Friday, March 6, 2020 at 8:30 AM E.T.

2020-02-25 10:27:00 | Shareholders Support the Election of Both HDF Nominees to Enzo Board of Directors

2020-02-25 09:59:00 | Enzo Biochem Announces Preliminary Results of Voting at Annual Shareholder Meeting

2020-02-19 17:16:00 | ISS Recommends Shareholders Vote AGAINST Enzo Proposal to Increase Size of Board

2020-02-19 08:30:00 | Enzo Biochem Reports Publication of Study Detailing Promising Activity of Drug Candidate SK1?I in a Model of Lupus

2020-02-12 09:18:32 | The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data

2020-02-11 08:30:00 | Enzo Biochem Announces Significant Milestone with Approval of Proprietary GenFlex Platform

2020-02-07 08:00:00 | Enzo Disappointed in Harbert’s Lawsuit Aimed at Disenfranchising Shareholders

2020-02-06 15:07:00 | Harbert Discovery Fund Files Lawsuit Seeking to Hold Enzo Board Accountable for Acts of Entrenchment and Illegal Maneuvers

2020-01-30 08:13:00 | Enzo Comments on Harbert’s Reaction to Providing Enzo Shareholders Additional Choices

2020-01-29 10:51:00 | Harbert Discovery Fund Comments on Enzo Biochem’s Entrenchment Maneuvers

2020-01-28 17:45:00 | Enzo Biochem Proposes to Increase Size of Board and Will Appoint Additional Highly Qualified, Diverse Independent Director in Near Future

2020-01-27 06:45:00 | Harbert Discovery Fund Sends Letter to Fellow Enzo Biochem Shareholders

2020-01-21 14:36:00 | All Three Proxy Advisory Firms Recommend Shareholders Vote FOR Change to the Board of Enzo Biochem on the Blue Card

2020-01-17 15:02:00 | Enzo Biochem Comments on ISS Report

2020-01-17 11:56:00 | ISS Recommends Shareholders Vote FOR the Election of Harbert Discovery Fund Nominee to Enzo Biochem Board

2020-01-16 13:03:00 | Glass Lewis Recommends Shareholders Vote For the Election of Both Harbert Discovery Fund Nominees to Enzo Biochem’s Board

2020-01-13 08:00:00 | Enzo Biochem Responds to Series of Misleading and Inaccurate Statements from Activist Hedge Fund Harbert

2020-01-08 09:00:00 | Harbert Discovery Fund Releases Detailed Investor Presentation Highlighting Case for Change at Enzo Biochem

2020-01-08 08:49:02 | How Does Enzo Biochem, Inc. NYSE:ENZ Affect Your Portfolio Volatility?

2019-12-31 10:48:00 | Enzo Biochem Appoints Rebecca J. Fischer to Board of Directors

2019-12-30 09:00:00 | Harbert Discovery Fund Sends Letter to Fellow Enzo Biochem Shareholders

2019-12-14 19:01:58 | Is Enzo Biochem, Inc. ENZ Going To Burn These Hedge Funds ?

2019-12-10 16:15:00 | Enzo Biochem Reports Fiscal First Quarter Results

2019-12-05 16:15:00 | Enzo Biochem Issues Open Letter to Shareholders

2019-12-05 12:00:00 | Enzo Biochem Schedules Teleconference to Discuss First Quarter 2020 Results Tuesday, December 10, 2019 At 4:30 PM E.T.

2019-11-09 09:18:41 | What Kind Of Shareholders Own Enzo Biochem, Inc. NYSE:ENZ?

2019-10-17 20:44:48 | Edited Transcript of ENZ earnings conference call or presentation 15-Oct-19 8:30pm GMT

2019-10-15 16:15:00 | Enzo Biochem Reports Fiscal Fourth Quarter and Full Year Financial Results

2019-10-11 09:00:00 | Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter and Fiscal Year 2019 Results Tuesday, October 15, 2019 at 4:30 PM E.T.

2019-10-10 08:06:32 | Does Enzo Biochem, Inc.'s NYSE:ENZ CEO Salary Reflect Performance?

2019-09-24 09:00:00 | New York State Health Department Approves Hepatitis B Virus Quantitative Clinical Assay

2019-09-17 09:00:00 | Harbert Discovery Fund Nominates Two Highly-Qualified Independent Candidates to Enzo Biochem Board

2019-09-10 07:33:05 | Investors Who Bought Enzo Biochem NYSE:ENZ Shares Five Years Ago Are Now Down 41%

2019-08-15 07:43:03 | Is Enzo Biochem NYSE:ENZ Using Debt In A Risky Way?

2019-08-05 09:00:00 | Enzo Biochem, Inc. Announces Issuance of United States Patent for Advanced Nucleic Acid Hybridization Probe Technology for Clinical and Research Applications